| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |